CD274 and neoplasm: In patients treated with PD‐L1 or PD‐1 inhibitors, differences in immune‐mediated AE frequencies could potentially be driven by T cells reacting to tumor antigens that are cross‐reactive against wild‐type protein in normal tissue.52